Let’s Reach Your Development Milestones Together

Gareth Sexton

Director, Business Development

 

Gareth Sexton is a forward-thinking professional who’s passionate about the next generation of healthcare, building relationships to support advanced analytics, and technologies bringing high quality medicine to patients faster. He brings over a decade of professional experience in healthcare and pre-clinical safety assessment, skilled in formulations and analytical chemistry, with knowledge of method development, validation, sample analysis for HPLC/UPLC, RP, SEC, and UV spec, among other analytical techniques.

Before joining ProtaGene, Gareth held technical/scientific, laboratory management, and client/account management roles. As an Analytical Chemistry Analyst at Charles River Laboratories, Gareth worked in formulations, focusing on both small and large molecules. He was recognized for his efforts as a key contributor in 2018 and 2019. He also worked as a Formulation Scientist and Analytical Chemistry Supervisor at Alta Sciences and notably optimized workflows and doubled instrumentation and staff. His strong desire to be client-facing led him to a Client Manager role in 2021.

Gareth holds a Bachelor of Science in Biochemistry and Molecular Biology from the University of Nevada, where he researched thiamin synthesis in transgenic plants.

Analytical Solutions from Research to Market

Group Created with Sketch.
Research
Preclinical
Group 2 Created with Sketch.

Discovery – Pre-clinical

Biologic Candidate Evaluation, Optimization and Selection into IND

Group 3 Created with Sketch.
Phase I
Phase II
Phase III
Group 4 Created with Sketch.

Phase I – Phase III

Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA

Group Created with Sketch.
Registration
Market
Group 2 Created with Sketch.

Registration – Market

Commercial-Stage Comparability Testing by Qualified Advanced Methods

Biologic Therapeutics
Platform Expertise

  • bullet Created with Sketch.

    mAbs

  • bullet Created with Sketch.

    Bispecifics/Multispecifics

  • bullet Created with Sketch.

    Recombinant Proteins—Including Complex, Highly Glycosylated Proteins

  • bullet Created with Sketch.

    Multi-subunit Complexes—Protein, Nucleotide, Ligand

  • bullet Created with Sketch.

    Fusion Proteins

  • bullet Created with Sketch.

    Enzyme Replacement Therapies

  • bullet Created with Sketch.

    ADCs and Protein Conjugates

  • bullet Created with Sketch.

    PEGylated Proteins

  • bullet Created with Sketch.

    Biosimilars

  • bullet Created with Sketch.

    Vaccines, Including Subunit/Recombinant

Cell and Gene Therapeutic Platform Expertise

  • bullet Created with Sketch.

    Capsid-based Vectors

  • bullet Created with Sketch.

    Complex, Envelope Vectors

  • bullet Created with Sketch.

    Non-viral Vectors

  • bullet Created with Sketch.

    Genetic Engineering